| Literature DB >> 33801670 |
Elodie Bacou1, Carrie Walk2, Sebastien Rider1, Gilberto Litta2, Estefania Perez-Calvo1.
Abstract
The redox system is essential for maintaining cellular homeostasis. When redox homeostasis is disrupted through an increase of reactive oxygen species or a decrease of antioxidants, oxidative distress occurs resulting in multiple tissue and systemic responses and damage. Poultry, swine and fish, raised in commercial conditions, are exposed to different stressors that can affect their productivity. Some dietary stressors can generate oxidative distress and alter the health status and subsequent productive performance of commercial farm animals. For several years, researchers used different dietary stressors to describe the multiple and detrimental effects of oxidative distress in animals. Some of these dietary challenge models, including oxidized fats and oils, exposure to excess heavy metals, soybean meal, protein or amino acids, and feeding diets contaminated with mycotoxins are discussed in this review. A better understanding of the oxidative distress mechanisms associated with dietary stressors allows for improved understanding and evaluation of feed additives as mitigators of oxidative distress.Entities:
Keywords: antioxidants; challenge models; diet; fish; gastrointestinal; oxidative distress; pigs; poultry
Year: 2021 PMID: 33801670 PMCID: PMC8066155 DOI: 10.3390/antiox10040525
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Summary of the dietary oxidative stress challenges models using oxidized fat in poultry, including type of fat, oxidation conditions, resultant fat characterization and inclusion level in feed, and results including growth performance impact, oxidative stress markers evaluated classified by enzymatic, non-enzymatic or oxidative damage.
| Animal (Age) | Type of Fat Source | Oxidation Conditions | PV, | Growth | Oxidative Distress Biomarkers | Ref. | ||
|---|---|---|---|---|---|---|---|---|
| Enzymatic | Non Enzymatic | Damage | ||||||
| Broiler chicken (28–42 d) | Fat blend | RT until a PV of 100 | 100 | No effect | Increased TBARS in blood and breast muscle | [ | ||
| Broiler chicken | 9% rapeseed oil | 15 mg/kg Fe2+, 7.5 mg/kg Cu2+, 660 mg/kg H2O2, stirring | 156 | Tendency to decrease live weight | No effect on GPX in liver | Vit E decreased in plasma, breast and thigh muscle, liver, heart and fat | Increased plasma TBARS | [ |
| Broiler chicken (1–39 d) | Soyabean oil | Heating, 95 °C, continuous bubbling air, | 180 | Decreased BW, gain, and FCR | Decreased serum and liver vitamin A and E | No effect plasma TBARS | [ | |
| Broiler chicken (1–21 d) | Soyabean oil | Heating, 90 °C, continuous bubbling, | 244 | No effect on gain, decreased intake, increased FCR | Decreased liver GPX, no effect plasma GPX, increased liver GPX, GSR | Increased plasma, liver T-AOC | Decreased liver TBARS, no effect plasma TBARS | [ |
| Laying hens | Soyabean oil | Air at RT, 3 months, heated 185 °C, cooled, heated | 21, 56, and 88 | Decreased egg production, increased FCR, no effect on intake | [ | |||
| Laying hens | Sunflower oil | Intermittent heating, 185 °C, air | 29.2 | Decreased FI, no other effect | Decreased plasma glutathione | Increased plasma, liver MDA, increased liver DNA damage, increased hepatic carbonyl, liver ROS | [ | |
| Laying hen (38–46 wks) | corn oil (2%) | Heating 100 °C | corn oil, 7.6 | Corn oil = decreased egg production, DFI, FCR and egg weight; CGM = decreased egg production and DFI | Tendency to decrease T-AOC | Increased pre-hierarchical follicle apoptosis, ovary MDA, | [ | |
| Broiler chicken (1–49 d) | Fat blend | Heating at 135–140°F | 0, 75, 150 | Decreased BWG, increased FCR | [ | |||
| Broiler chicken (1–49 d) | Fat blend | Heating at 135–140°F | 0, 75, 150 | [ | ||||
| Broiler chicken (1–21 d) | Poultry fat | Heating, 80 °C, aeration, stirring | 0, 3, or 6 | No effect | Increased GPX in RBC and in liver | [ | ||
| Broiler chicken (10–47 d) | Poultry fat | Fried, 110–120 °C, | 38.7 | No effect on gain, improved FCR | Increase TBARS in thigh meat over time (stored chilled) | [ | ||
| Broiler chicken (1–21 d) | Soyabean oil | Heating, 200 °C | 4, 25, 57, or 73 | No effect on gain or FCR | Decreased ileum SOD, CAT | Decreased liver T-AOC | Increased liver, jejunum MDA | [ |
| Broiler chicken (1–42 d) | Sunflower oil | O2, aerated, heating 70–80 °C | 148 | No effect | Decreased plasma SOD, no effect plasma GPX | No effect plasma MDA | [ | |
S = starter diet; GF = grower/finisher diet; CGM = corn gluten meal; RT, room temperature; PV, peroxide value; BWG = Body weight gain; FCR = feed conversion ratio; DFI = Daily feed intake; SOD = superoxide dismutase; CAT = catalase; GPX = glutathione peroxidase; GSR = glutathione reductase; MDA = malondialdehyde, TBARS = thiobarbituric acid reactive substances; T-AOC = total antioxidant capacity; RBC = red blood cells.
Summary of the dietary oxidative challenges models based on oxidized fat discussed within this review in swine, including type of fat, oxidation conditions, resultant fat characterization and inclusion level in feed, and results, including growth performance impact, oxidative stress markers evaluated classified by enzymatic, non-enzymatic or oxidative damage.
| Animal Phase (Age/BW) | Type of Fat Source and Inclusion Level | Oxidation Conditions | PV | Growth Performance Effect | Oxidative Distress Biomarkers | Ref. | ||
|---|---|---|---|---|---|---|---|---|
| Enzymatic | Non Enzymatic | Damage | ||||||
| G pigs (80 kg) | Corn oil (5%) | Heating 95 °C and bubbling air | 150 mEq/kg | Decreased BWG | Decreased GPX | Decreased vit E in liver and | No effect on TBARS nor free carbonyl at plasma | [ |
| Weaned piglets (28 d) | Corn oil (3, 6 or 9%) | Heating at 185 °C during 12 h with force air flow | 5.7 meq O2/kg | Decreased BWG | Decreased vit E in serum but no effect on Se levels at serum. | No effect on TBARS at serum. | [ | |
| Weaned piglets | Corn oil (5%) | Heating at 65° for 12 d with forcing air | 163 mEq/kg oil | Increased FCR | Decreased T-AOC and vitamin E at serum. | No effect on MDA, PC, nor 8-OH-2dG at serum. | [ | |
| Weaned piglets (28 d) | Fish oil (5%) | Addition of FeSO4⋅7H2O, CuSO4⋅5H2O, H2O2 and water, and | 786.50 meq O2/kg | Decreased BWG | Decreased SOD, GPX | Increased MDA in plasma and liver | [ | |
| Weaned piglets (6.6 kg) | DDGS (30%) | From ethanol commercial plant | 84.1 mEq/kg | Decreased BWG | Increased vit E in loin muscle | No effect on TBARS in loin muscle | [ | |
| Weaned piglets (28 d) | Soybean oil (SO; 10%) | Heating at 45 °C for 288 h, 90 °C for 72 h, or 180 °C for 6 h | 11.5, 19.1, and 13.4 mEq/kg feed | Peroxidized SO at 90 °C reduced ADG ADFI | ISP increased at serum and urine but no effect on TBARS, 8-OH-2dG at serum, urine nor liver | [ | ||
| G pigs (25 kg) | Soybean oil (10%) | Heating 45 °C for 288 h, 90 °C for 72 h, or 180 °C for 6 h); | 96, 145, and 4.0 mEq/kg, | Decreased BWG and increase FCR | [ | |||
| Weaned piglets (21 d) | Soybean oil (6%) | Heating 80 °C for 12 h and continous bubble air | Decreased BWG, FI and increased FCR | T-AOC and Vit E in serum decreased; | Decreased MDA and PC increased but no effect on 8-OH-2dG | [ | ||
| Weaned piglets (21 d) | Soybean oil (6%) | Heating (80 °C) and constant oxygen flow for 0, 6, 9and 12 d | Reduced FI and BWG | Decreased T-AOC | Increased MDA in the jejunal mucosa | [ | ||
| Sows (85 d gestation–d21 lactation) | Corn oil (2%) | Heating at 95°C for 72 h and bubbling air | 250 mEq/kg | No effect on reproductive performance but decreased feed intake during lactation | Decreased SOD and Mn-SOD at serum across lactation but no effect on GPx | No effect on vit E nor C | No effect on MDA | [ |
PV = peroxide value; BWG = Body weight gain; FCR = feed conversion ratio; DFI = Daily feed intake; SOD = superoxide dismutase; CAT = catalase; GPX = glutathione peroxidase; GSR = glutathione reductase; MDA = malondialdehyde, TBARS = thiobarbituric acid reactive substances; T-AOC = total antioxidant capacity, ISP = F2-isoprostanes; PC = protein carbonyls, 8-OH-2dG = 8-hydroxy-2′-deoxyguanosine.
Summary of the dietary oxidative challenges models based on oxidized fat discussed within this review in fish, including type of fat, oxidation conditions, resultant fat characterization and inclusion level in feed, and results, including growth performance impact, oxidative stress markers evaluated classified by enzymatic, non-enzymatic or oxidative damage.
| Animal Phase (Age/BW) | Type of Fat Source and Inclusion Level | Oxidation Conditions | PV | Growth Performance Effect | Oxidative Distress Biomarkers | Ref. | ||
|---|---|---|---|---|---|---|---|---|
| Enzymatic | Non Enzymatic | Damage | ||||||
| Atlantic salmon (67g) | Oxidized herring oil | Aerating at room temperature for 1 month | 200 mEq/kg | No effect | Increased TBARS in liver, fillet and large intestine content | [ | ||
| Rainbow trout (1.5 g) | Oxidized salmon oil (8%) | Bubbling air into oil for 90 h at 50 °C | 234 mEq/kg, | No effect | Increased SOD, CAT, GPX gene expression | [ | ||
| Rainbow trout (66 g and 1.5 g) | Oxidized fish oil (12%) | Bubbling air into oil for 6 days at 50 °C | 93 and 144 mEq/kg | Reduced wet weight | Increased whole boy GST, CAT, GR and GPX gene expressions | Reduced whole body Vitamin E | Increased TBARS and ISP | [ |
| Artic charr (2.5 g) Tilapia (1.7 g) | Oxidized herring oil (152.7 g/kg; charr and 76.2 g/kg tilapia) | Bubbling with pure oxygen at 50–70 °C for 2–7 days | 183, 56, 33 mEq/kg (Charr) | Decreased FBW (highest level oxidized oil; charr) | Increased hepatic CAT and GPX activities and decreased SOD activities (Charr) | [ | ||
| Sea bream, Turbot and Halibot | Oxidised anchoui/Sardine oil (12.6%) | Bubbling air into oil for 24 h at 50 °C | 42 mEq/kg | Decreased FBW and SGR (all species) | Increased hepatic SOD, CAT and GPX activities (Sea bream), hepatic GST and GR acitivities (Turbot) and hepatic SOD, GST and GSR activities (Halibot) | No effect (Sea bream) | [ | |
| Sea bream (1.2 g) | Oxidized tuna orbital oil (12.6%) | Heating for 24 h at 50 °C in oxygen-rich atmosphere | 42 mEq/kg | No effect | Increased SOD and CAT activities and reduced GPX activities (30 days) | Increased GSH (60 days) | Increased hepatic MDA (30 and 60 days) and ISP (60 days) | [ |
| Sturgeon (0.4 g) | Oxidized capelin oil (4 and 8%) | Bubbling air into oil for 48 h at 50 °C | 245 mEq/kg | Reduced growth | Increased whole body SOD and CAT activities | Increased TBARS and ISP | [ | |
| African catfish (15 g) | Blender cod-live/corn oil (1:1; 60 g/kg) | Aeration for 30 days at 22 °C | Decreased FBW | Decreased vitamin E in muscle, liver, plasma, heart and spleen | [ | |||
| Large amount bass (31.5 g) | Oxidized fish oil (70 g/kg) | Heating at 50 °C with continous air injections | 155, 275 and 574 mEq/kg | Increased FBW and WG with lowest level oxidized oil | Increased hepatic SOD and GPX activities with highest dose of oxidized oil | Increased hepatic T-AOC with highest dose of oxidized oil | Increase hepatic MDA with highest dose of oxidized oil | [ |
| Blunt snout bream (5.2 g) | Oxidized salmon oil (2; 4 and 6%) | Heating at 37 °C for 14 days with air injections | 8, 16 and 23 mmol/kg | Decreased FBW, SGR and FCR in dise response manner | Increased SOD and GPX with increased oxidized oil | Decreased GSH with increasing oxidized oil | Increased MDA with increasing oxidized oil | [ |
| Rhynchocypris agowski Dybowski (4.5 g) | Oxidized fish oil (4%) | Heating at 70 °C | 107, 195, 293 and 403 mEq/kg | Reduced SGR and BWG (highest levels of oxidized oil) | Decreased GPX, CAT and SOD in dose response manner in liver and muscle | Decreased GSH and T-AOC in liver, intestinal tract and muscle in dose response manner | Increased hepactic and intestinal MDA | [ |
PV = peroxide value; FBW = Final body weight; WG = weight gain; SGR = specific growth rate; SOD = superoxide dismutase; CAT = catalase; GPX = glutathione peroxidase; GSR = glutathione reductase; GSH = glutathione; GST = Glutathione-S-Transferase; MDA = malondialdehyde, TBARS = thiobarbituric acid reactive substances, ISP = isoprostanes; 4-HNE = 4-hydroxyalkenals; T-AOC = total antioxidant capacity.
Summary of the dietary oxidative challenge models using minerals imbalances in poultry and swine diets, including nutrient level, and results, including effect on growth performance and markers of oxidative distress classified as enzymatic, non-enzymatic, or damage.
| Animal | Nutrient | Growth | Oxidative Distress Biomarkers | Ref. | ||
|---|---|---|---|---|---|---|
| Enzymatic | Non Enzymatic | Damage | ||||
| Male pullets | CuSO4 (300 mg/kg feed), As2O3 (30 mg/kg feed) | Decreased small intestine CAT, GPX | Decreased small intestine AHR (anti-hydroxyl radical), increased small intestine MDA | [ | ||
| Broiler chicken (21–42 d) | CuSO4 (250 mg/kg feed) | Decreased blood, liver SOD, CAT | Decreased blood, liver GSH | Increased liver, blood MDA | [ | |
| Male pullets | As2O3 | Decrease thymus, bursa, spleen CAT, GPX | Decreased thymus, bursa, spleen GSH | Increased thymus, bursa, spleen MDA | [ | |
| Broiler chicken (0–21 d) | Met (0.05 or 0.25%) | 0.25% Met increased BW, daily gain, improved FCR | 0.25% Met increased GPX in serum | 0.25% Met increased liver GSSG, decreased liver, small intestine GSH:GSSG, decreased small intestine GSH, GSSG | [ | |
| Broiler chicken (0–21 d) | Met (99 or 119% of requirement) | 119% Met improved gain, FCR in light weight chicks | 119% Met increased serum SOD, increased liver GPX | 119% Met increased liver GSH:GSSG | 119% Met decreased liver MDA | [ |
| Broiler chicken (0–42 d) | Met (52 or 70% of requirement) | Decreased small intestine SOD, CAT, GPX | Decreased small intestine ability to inhibit hydroxyl radicals, decreased small intestine GSH | Increased small intestine MDA | [ | |
| Broiler chicken (0–42 d) | Met (52 or 70% of requirement) | Decreased cecal tonsil SOD, CAT, GPX, | Decreased cecal tonsil ability to inhibit hydroxyl radicals, decreased cecal tonsil GSH | Increased cecal tonsil MDA | [ | |
| Weaned piglets (21 d) | 225 mg Cu/kg dietCuSO4 vs. TBCC | No effect after 33 days of supplementation independently of Cu form | Decreased total liver GSH | [ | ||
| Weaned piglets (21 d) | 225 mg Cu/kg dietCuSO4 vs. TBCC | No effect | Increased duodenal MDA | [ | ||
| Growing pigs (6 5–115 kg) | Cu, Fe, Mn, Zn at NRC vs. commercial trace mineral supplement | Commercial trace mineral supplement increased TBARS, PC, and 8-OH-2dG | [ | |||
| Growing pigs (31–16 kg) | Mn (20 vs. 150 mg/kg) | Decreased in BWG | Increased GPX and CAT in plasma and CAT in liver | Increase T-AOC in muscle | No effect TBARS in muscle | [ |
Met, methionine; BWG = Body weight gain; FCR = feed conversion ratio; DFI = Daily feed intake; SOD = superoxide dismutase; CAT = catalase; GPX = glutathione peroxidase; GSR = glutathione reductase; MDA = malondialdehyde, TBARS = thiobarbituric acid reactive substances; T-AOC = total antioxidant capacity; PC = protein carbonyls, 8-OH-2dG = 8-hydroxy-2′-deoxyguanosine.
Summary of the dietary oxidative challenges models using soybean meal in fish diets, including inclusion level and results, including effect on zootechnicalperformance and markers of oxidative distress classified as enzymatic, non-enzymatic, or damage.
| Animal | Protein | Growth | Oxidative Distress Biomarkers | Ref. | ||
|---|---|---|---|---|---|---|
| Enzymatic | Non Enzymatic | Damage | ||||
| Turbot (9.6 g) | SBM (37.9%) | Decreased FBW, SGR and FI | Decreased intestine SOD and GPX gene expression | Decreased intestinal T-AOC | Increased intestinal MDA | [ |
| Turbot (7.5 g) | SBM (35.10%) | Decreased FBW and SGR | Decreased hepatic SOD activity | [ | ||
| Yellow catfish (17 g) | SBM (36%) | Decreased FBW and increased FCR | Decreased intestine CAT activity | Decreased intestine GSH | Increased intestine MDA and protein carbonyl | [ |
| Large yellow croaker (7.7 g) | SBM (30.6%) | Decreased FBW and SGR | Decreased intestine SOD activity | Decreased intestinal T-AOC | Increased intestinal MDA | [ |
| Totoaba (7.5 g) | SBM (19.5 and 38.9%) | Reduced growth (SBM 38.9%) | Increased SOD activity (SBM 19.5%) | Increased hepatic MDA | [ | |
FBW = Final body weight gain; SGR = Specific growth rate; FI = feed intake; SOD = superoxide dismutase; GPX = glutathione peroxidase; MDA = malondialdehyde; T-AOC = total antioxidant capacity.
Summary of the dietary oxidative challenges models using mycotoxins in poultry, swine and fish diets, including nutrient and concentration and results, including effect on growth performance and markers of oxidative stress classified as enzymatic, non-enzymatic, or damage.
| Animal Phase (Age/BW) | Mycotoxin and Level | Growth Performance | Oxidative Distress Biomarkers | Ref. | ||
|---|---|---|---|---|---|---|
| Enzymatic | Non Enzymatic | Damage | ||||
| Broiler chickens (10–31 d) | DON (7.5 mg/kg) | Increased XOR and HMOX in the jejunum | [ | |||
| Broiler chickens (1–15 d) | DON (5 mg/kg) +FB1(20 mg/kg) | No impact on gain or FCR | Increased HMOX in the ileum, and down-regulated XDH in the jejunum | [ | ||
| Broiler chickens (1–20 d) | FB1(10 mg/kg) | Decreased intake and gain; no impact on FCR | Increased liver CAT, no effect on SOD | Increased TBARS in serum but not in liver | [ | |
| Broiler chickens (1–21 d) | T2 toxin (0, 0.5, 1, 2 mg/kg) | Decreased expression of GPX, CAT, SOD | Increased MDA | [ | ||
| Broiler chickens (1–21 d) | FB1 (100 mg/kg) | Increased FCR | Increased CAT and no effect on SOD | lncreased ascorbic acid | Increased MDA, no effect on non-protein thiols or GST | [ |
| Broiler chickens (1–21 d) | T2 toxin (0, 0.5, 1, or 2 mg/kg) | Decreased SOD and CAT | Decreased GSH-Px | Increased MDA | [ | |
| Broiler chickens (12–21 d) | FB1 (2.5, 5, 10 mg/kg) | Decreased gain, no effect FI | Decreased serum and liver SOD and GPX | Decreased liver and plasma GST | [ | |
| Broiler chickens (1–35 d) | DON (10 mg/kg) | Increased jejunum TBARS and blood lymphocyte DNA damaged | [ | |||
| Broiler chickens (14–28 d) | DON (3.4 or 8.2 mg/kg) + ZEA (3.4 or 8.3 mg/kg) | Increased GPX in blood and decreased in liver; no impact in duodenal mucosa nor SOD in RBCs | No impact on vitamin E in RBCs | Increased MDA in liver; no impact on MDA in duodenal mucosa or thioredoxin reductase (TrxR) in the liver | [ | |
| Broiler chickens (1–42 d) | FB1 (200 mg/kg) | No effect | Increased liver ROS, H2O2, MDA, carbonyl (protein oxidation products) | [ | ||
| Broiler chickens (21–24 d or 21–35 d) | AFB1 (149 ug/kg) | Decreased FI and BWG | No effect on plasma GPX | Decreased plasma GSH | No effect on TBARS at plasma or liver; increased liver gene expression of GPX4 and decreased gene expression of GSSG | [ |
| Broiler chickens (21–28 d) | DON (5, 12, 25 mg/kg) + T2 toxin (0.23, 1.2, 2.4 mg/kg) | Increased liver GPX | Increased liver GPX | No impact on liver MDA; | [ | |
| Broiler chickens (3–28 d) | AFB1 (1 mg/kg) | Decreased liver protein expression of endogenous antioxidant genes (Nrf2, HO-1, GPX1, NQO1, GCLC) | [ | |||
| Broiler chickens (6–14 d) | DON (19.3 mg/kg) | Decreased GSH in the jejunum and ileum | Increased TBARS in the jejunum. No effect on superoxide anion production/pathways in the jejunum/ileum | [ | ||
| Duck (1–21 d) | OTA (2 mg/kg) | Decreased liver CAT; no effect on SOD | No effect liver T-AOC or GPX | No effect liver MDA or mRNA expression of antioxidant genes (HMOX-1, Nrf2) | [ | |
| Duck (14–47 d) | DON (4.9 mg/kg) +ZEA (0.66 mg/kg) | decrease in liver MDA; increased free sulfhydryl group and reducing power in liver | [ | |||
| Weaned piglets (11.7 kg) | DON (4 mg/kg) and T2 toxin (3 mg/kg) | DON and T2 decreased DGW and increased FCR | No effect on erythrocyte GPX | No effect on plasma and 24-h urinary MDA excretion rate | [ | |
| Weaned piglets (12.27 kg) | ZEA (1 mg/kg) | Decreased the level of SOD and GPX in the liver | Decreased the level of T-AOC | Increased MDA in the liver | [ | |
| Weaned gilts (14 kg) | ZEA (0.1; 0.5; 1 and 1.5 mg/kg) | Decreased SOD and GPX in ileum and MLNs | MDA increased quadratically in the ileum and MLNs. mRNA and protein expression of Nrf2, GPX1, NQO1, HMOX1, Gclm, and Gclc | [ | ||
| Weaned piglets (27 d) | DON (1.2 and 3.2 mg/kg) | Decreased ADG | Decreased GPX in jejunal mucosa | Tended to increase MDA in jejunal mucosa | [ | |
| Weaned piglets (21 d-35 d) | DON (4 mg/kg) | Decreased ADG, ADFI and FCR | Decreased SOD and GPX in serum | Decreased GSH, and T-AOC in serum | Increased MDA in serum | [ |
| Weaned piglets (21 d-42 d) | DON (3.6 mg/kg) | Decreased ADG and ADFI | Decreased SOD in jejunum and GPX in liver | Decreased GPX2 expression levels in jejunum | Increased MDA in serum | [ |
| Weaned piglets (6 kg) | DON (3.1 mg/kg) + ZEA (1.8 mg/kg) | No effect on growth performance | Increased SOD in liver | No effect GSH in plasma and liver | Increased MDA in plasma | [ |
| Weaned piglets (9.1 kg) | AFB1 (320 mg/kg) | Decrease on BW | Increased 8-OHG and 8-OHdG level as well as in PC content | [ | ||
| Weaned piglets (9.8 kg) | OTA (0.05 mg/kg) | Increased SOD in both kidney and duodenum but no effect on CAT and GPX activities | No effect on expression of HMOX1 gene at gut or kidney levels | [ | ||
| Growing pigs (15–50 kg BW) | OTA (0.5 or 2.5 mg/kg) | Decreased BWG, FI and FCR | [ | |||
| GF pigs (40 kg to 170 kg) | OTA (0.025 mg/kg) | Decreased BWG and FCR but not FI | [ | |||
| Nile tilapia (27 g) | AFB1 (200 µg/kg) | Decreased serum CAT activity | Increased MDA in serum | [ | ||
| Nile tilapia (20 g) | AFB1 (1641 µg/k) | Decreased feed intake and FER | [ | |||
| Nile tilapia (15 g) | T-2 (24.3 mg/kg) | Decreased survival rate and weight gain | Increased GST activity in liver | [ | ||
| Common carp (77 g) | T-2 (5.3 mg/kg) | Decreased liver CAT activity and GPX activity in caudal kidney | Increased TBARS in liver and caudal kidney | [ | ||
AFB1 = Aflatoxin B1; FB1 = Fumonisin B1; OTA = Ochratoxins; DON = Deoxynivalenol; ZEA = zearalenone; BWG = Body weight gain; FCR = feed conversion ratio; DFI = Daily feed intake; FER = Feed efficiency ratio; XOR = Xanthine oxidoreductase; XDH = Xanthine dehydrogenase; SOD = superoxide dismutase; CAT = catalase; GPX = glutathione peroxidase; GSR = glutathione reductase; GST = Glutathione-S-transferase; MDA = malondialdehyde; TBARS = thiobarbituric acid reactive substances; MNLs = Mesenteric lymph nodes; RBC = Redd blood cells; GSSG = glutathione disulfide; Nrf2 = nuclear factor erythroid 2-related factor 2; NQO1 = quinone oxidoreductase 1, HMOX = hemeoxygenase; Gclm = glutamate-cysteine ligase; Gclc = glutamate-cysteine ligase; 8-OHG = 8-hydroxyguanosine; 8-OHdG = 8-oxo-2′-desoxyguanosine, PC = protein carbonyl.